Patents by Inventor Scott Ludecker
Scott Ludecker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11839390Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: April 13, 2021Date of Patent: December 12, 2023Assignee: MISONIX, LLCInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Patent number: 11147570Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: February 6, 2019Date of Patent: October 19, 2021Assignee: MISONIX, INCORPORATEDInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20210228225Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: April 13, 2021Publication date: July 29, 2021Inventors: PAUL MIKUS, SCOTT ISOLA, DAN VOIC, SCOTT LUDECKER, ALEXANDER DARIAN
-
Patent number: 10973537Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: September 10, 2018Date of Patent: April 13, 2021Assignee: MISONIX, INCORPORATEDInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20190167285Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: February 6, 2019Publication date: June 6, 2019Inventors: Paul MIKUS, Scott ISOLA, Dan VOIC, Scott LUDECKER, Alexander DARIAN
-
Patent number: 10299809Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: November 5, 2015Date of Patent: May 28, 2019Assignee: MISONIX, INCORPORATEDInventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20190015123Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: September 10, 2018Publication date: January 17, 2019Inventors: PAUL MIKUS, Scott ISOLA, Dan VOIC, Scott LUDECKER, Alexander DARIAN
-
Patent number: 10092308Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: GrantFiled: November 12, 2015Date of Patent: October 9, 2018Assignee: MISONIX, INC.Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20160128707Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: November 5, 2015Publication date: May 12, 2016Inventors: PAUL MIKUS, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian
-
Publication number: 20160128708Abstract: A two phase method for reducing the formation of biofilm includes an evacuation of ambient air from a region about the surgical or treatment site, to extract airborne or aerosolized bacteria ejected from the site by the treatment. The extracted bacteria are prevented from settling back onto the cleansed tissue surface, thus at least reducing colonial bacteriological growth and concomitantly exuded biofilm material. A second phase involves the attachment of one or more ultrasonic transducers to the patient over or near a surgical treatment site after the surgery is terminated. Each applied ultrasonic transducer is used to vibrate the patient's tissues at the treatment site to disrupt biofilm formation.Type: ApplicationFiled: November 12, 2015Publication date: May 12, 2016Inventors: Paul Mikus, Scott Isola, Dan Voic, Scott Ludecker, Alexander Darian